Posted by Michael Wonder on 25 Jan 2023
NICE approves new migraine drug for NHS use in England and Wales
25 January 2023 - Drugs regulator recommends eptinezumab for adults when three previous treatments have failed.
Thousands of people in England and Wales who suffer from migraines could benefit from a drug that has been approved on the NHS.
